Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Non-cash Items (2016 - 2020)

Historic Non-cash Items for Myriad Genetics (MYGN) over the last 11 years, with Q2 2020 value amounting to $4.8 million.

  • Myriad Genetics' Non-cash Items fell 1272.73% to $4.8 million in Q2 2020 from the same period last year, while for Jun 2020 it was $4.8 million, marking a year-over-year decrease of 1272.73%. This contributed to the annual value of $4.8 million for FY2020, which is 1272.73% down from last year.
  • As of Q2 2020, Myriad Genetics' Non-cash Items stood at $4.8 million, which was down 1272.73% from $4.9 million recorded in Q4 2019.
  • Myriad Genetics' Non-cash Items' 5-year high stood at $7.5 million during Q2 2017, with a 5-year trough of $2.2 million in Q1 2017.
  • Its 5-year average for Non-cash Items is $5.6 million, with a median of $5.9 million in 2018.
  • As far as peak fluctuations go, Myriad Genetics' Non-cash Items crashed by 7172.13% in 2016, and later skyrocketed by 21818.18% in 2018.
  • Quarter analysis of 5 years shows Myriad Genetics' Non-cash Items stood at $3.3 million in 2016, then soared by 124.24% to $7.4 million in 2017, then dropped by 14.86% to $6.3 million in 2018, then fell by 22.22% to $4.9 million in 2019, then dropped by 2.04% to $4.8 million in 2020.
  • Its Non-cash Items was $4.8 million in Q2 2020, compared to $4.9 million in Q4 2019 and $5.5 million in Q2 2019.